Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal methylprednisolone versus placebo for chronic complex regional pain syndrome type 1
NL-OMON20155Suspended
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) comparing Intrathecal Depo-Medrol with Placebo (2 arms). Primary endpoint: Pain relief at 6 weeks. Started Aug 2005; status: suspended.
02
Drugs
methylprednisolone
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on NL-OMON20155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20155.